Ionis Pharmaceuticals, Inc. (IONS)
27.00
-0.22
(-0.81%)
USD |
NASDAQ |
Nov 20, 15:00
Ionis Pharmaceuticals 30-Day Average Daily Volume : 4.128M for Nov. 19, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| November 19, 2026 | 4.128M |
| November 18, 2026 | 4.137M |
| November 17, 2026 | 4.128M |
| November 16, 2026 | 4.051M |
| November 13, 2026 | 3.978M |
| November 12, 2026 | 3.857M |
| November 11, 2026 | 3.718M |
| November 10, 2026 | 3.587M |
| November 09, 2026 | 3.360M |
| November 06, 2026 | 2.834M |
| November 05, 2026 | 2.944M |
| November 04, 2026 | 3.060M |
| November 03, 2026 | 3.041M |
| November 02, 2026 | 3.049M |
| October 30, 2026 | 3.114M |
| October 29, 2026 | 3.309M |
| October 28, 2026 | 3.384M |
| October 27, 2026 | 3.592M |
| October 26, 2026 | 3.739M |
| October 23, 2026 | 3.832M |
| October 22, 2026 | 3.804M |
| October 21, 2026 | 3.739M |
| October 20, 2026 | 3.764M |
| October 19, 2026 | 3.987M |
| October 16, 2026 | 3.973M |
| Date | Value |
|---|---|
| October 15, 2026 | 4.062M |
| October 14, 2026 | 4.041M |
| October 13, 2026 | 4.036M |
| October 12, 2026 | 4.004M |
| October 09, 2026 | 4.000M |
| October 08, 2026 | 3.893M |
| October 07, 2026 | 3.853M |
| October 06, 2026 | 3.836M |
| October 05, 2026 | 3.836M |
| October 02, 2026 | 3.831M |
| October 01, 2026 | 3.825M |
| September 30, 2026 | 3.862M |
| September 29, 2026 | 3.881M |
| September 28, 2026 | 3.818M |
| September 25, 2026 | 3.738M |
| September 24, 2026 | 3.572M |
| September 23, 2026 | 3.424M |
| September 22, 2026 | 3.386M |
| September 21, 2026 | 3.325M |
| September 18, 2026 | 3.241M |
| September 17, 2026 | 3.082M |
| September 16, 2026 | 3.017M |
| September 15, 2026 | 2.841M |
| September 14, 2026 | 2.721M |
| September 11, 2026 | 2.608M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Alnylam Pharmaceuticals, Inc. | 2.712M |
| Arrowhead Pharmaceuticals, Inc. | 2.135M |
| BridgeBio Pharma, Inc. | 2.799M |
| Biogen, Inc. | 1.237M |
| TG Therapeutics, Inc. | 1.906M |